Literature DB >> 23960016

Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.

João Lavrado1, Pedro M Borralho, Stephan A Ohnmacht, Rui E Castro, Cecília M P Rodrigues, Rui Moreira, Daniel J V A dos Santos, Stephen Neidle, Alexandra Paulo.   

Abstract

G-quadruplex (G4) DNA structures in telomeres and oncogenic promoter regions are potential targets for cancer therapy, and G4 ligands have been shown to modulate telomerase activity and oncogene transcription. Herein we report the synthesis and G4 thermal stabilisation effects, determined by FRET melting assays, of 20 indolo[3,2-b]quinolines mono-, di-, and trisubstituted with basic side chains. Molecular modelling studies were also performed in an attempt to rationalise the ligands' binding poses with G4. Overall, the results suggest that ligand binding and G4 DNA thermal stabilisation increase with an N5-methyl or a 7-carboxylate group and propylamine side chains, whereas selectivity between G4 and duplex DNA appears to be modulated by the number and relative position of basic side chains. From all the indoloquinoline derivatives studied, the novel trisubstituted compounds 3 d and 4 d, bearing a 7-(aminoalkyl)carboxylate side chain, stand out as the most promising compounds; they show high G4 thermal stabilisation (ΔTm values between 17 and 8 °C) with an inter-G4 ΔTm trend of Hsp90A>KRas21R≈F21T>c-Kit2, 10-fold selectivity for G4 over duplex DNA, and 100-fold selectivity for the HCT116 cancer cell line (IC50 and IC90: <10 μM) over primary rat hepatocytes. Compounds 3 d and 4 d also decreased protein expression levels of Hsp90 and KRas in HCT116 cancer cells.
Copyright © 2013 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  G‐quadruplexes; alkaloids; cancer; cryptolepine; indoloquinolines

Mesh:

Substances:

Year:  2013        PMID: 23960016     DOI: 10.1002/cmdc.201300288

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  9 in total

1.  Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Authors:  Steven D Shnyder; Colin W Wright
Journal:  Prog Chem Org Nat Prod       Date:  2021

2.  Targeting G-quadruplex DNA with synthetic dendritic peptide: modulation of the proliferation of human cancer cells.

Authors:  Soumi Biswas; Satyabrata Samui; Apurba K Das; Sanjeev Pasadi; K Muniyappa; Jishu Naskar
Journal:  RSC Adv       Date:  2020-07-14       Impact factor: 4.036

3.  Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.

Authors:  Hugo Brito; Ana Cláudia Martins; João Lavrado; Eduarda Mendes; Ana Paula Francisco; Sofia A Santos; Stephan A Ohnmacht; Nam-Soon Kim; Cecília M P Rodrigues; Rui Moreira; Stephen Neidle; Pedro M Borralho; Alexandra Paulo
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

4.  KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.

Authors:  João Lavrado; Hugo Brito; Pedro M Borralho; Stephan A Ohnmacht; Nam-Soon Kim; Clara Leitão; Sílvia Pisco; Mekala Gunaratnam; Cecília M P Rodrigues; Rui Moreira; Stephen Neidle; Alexandra Paulo
Journal:  Sci Rep       Date:  2015-04-08       Impact factor: 4.379

Review 5.  Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.

Authors:  Manuela Porru; Luca Pompili; Carla Caruso; Annamaria Biroccio; Carlo Leonetti
Journal:  J Exp Clin Cancer Res       Date:  2018-03-13

6.  G-Quadruplex DNA and RNA.

Authors:  Danzhou Yang
Journal:  Methods Mol Biol       Date:  2019

Review 7.  Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?

Authors:  Hidayati Husainy Hasbullah; Marahaini Musa
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

Review 8.  Therapeutic Targets of KRAS in Colorectal Cancer.

Authors:  Shafia Rahman; Shimon Garrel; Michael Gerber; Radhashree Maitra; Sanjay Goel
Journal:  Cancers (Basel)       Date:  2021-12-11       Impact factor: 6.639

Review 9.  Major Achievements in the Design of Quadruplex-Interactive Small Molecules.

Authors:  Eduarda Mendes; Israa M Aljnadi; Bárbara Bahls; Bruno L Victor; Alexandra Paulo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.